Rhythm Pharmaceuticals Imcivree Net Revenue FY24 Expected To Be About $130 Million
ReutersJan 10, 2025 1:27 PM
Jan 10 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O:
RHYTHM PHARMACEUTICALS INC: IMCIVREE NET REVENUE FY24 EXPECTED TO BE ABOUT $130 MILLION
RHYTHM PHARMACEUTICALS: ON TRACK TO REPORT TOPLINE DATA FROM GLOBAL PHASE 3 TRIAL EVALUATING SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OBESITY IN H1 2025
RHYTHM PHARMACEUTICALS: PLAN TO INITIATE NEW PHASE 2 TRIAL EXPLORING SETMELANOTIDE IN PRADER-WILLI SYNDROME
Further company coverage: RYTM.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Tesla Is About to Launch a New Vehicle. It May Be a Game-Changer.
Key PointsTesla says the first builds of a more affordable model happened in June, with volume production planned for the second half of 2025.The new car will likely slot below today's Model Y and lean into Tesla's self-driving roadmap.Model 3 transformed Tesla's business. While this launch may be sThe Motley Fool
an hour ago
Investing in AI Infrastructure
TradingKey - Artificial intelligence is one of the more-hyped technologies of the decade. Autonomic systems, chatbots, and generative models populate the headlines.TradingKey
16 hours ago
U.S. August PCE Preview: Four-Run PCE Bounce Challenges the Fed’s Three-Cut Plan
TradingKey - The U.S. Bureau of Economic Analysis (BEA) will release the August Personal Consumption Expenditures (PCE) Price Index on Friday, September 26, with markets closely watching how much tariff pass-through effects have influenced inflation.TradingKey
Thu, Sep 25
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
Tradingkey
